Global Microbiome Drugs Market Size, Status and Forecast 2022

Global Microbiome Drugs Market Size, Status and Forecast 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Dosage Form
1.2.3 Enteric Capsules
1.3 Market by Application
1.3.1 Global Microbiome Drugs Market Share by Symptom: 2016 VS 2021 VS 2027
1.3.2 Gastrointestinal Disorders
1.3.3 Autoimmune Disorders
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Drugs Market Perspective (2016-2027)
2.2 Microbiome Drugs Growth Trends by Regions
2.2.1 Microbiome Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microbiome Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Microbiome Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Microbiome Drugs Industry Dynamic
2.3.1 Microbiome Drugs Market Trends
2.3.2 Microbiome Drugs Market Drivers
2.3.3 Microbiome Drugs Market Challenges
2.3.4 Microbiome Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Drugs Players by Revenue
3.1.1 Global Top Microbiome Drugs Players by Revenue (2016-2021)
3.1.2 Global Microbiome Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Microbiome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiome Drugs Revenue
3.4 Global Microbiome Drugs Market Concentration Ratio
3.4.1 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Drugs Revenue in 2020
3.5 Microbiome Drugs Key Players Head office and Area Served
3.6 Key Players Microbiome Drugs Product Solution and Service
3.7 Date of Enter into Microbiome Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Drugs Breakdown Data by Type
4.1 Global Microbiome Drugs Historic Market Size by Type (2016-2021)
4.2 Global Microbiome Drugs Forecasted Market Size by Type (2022-2027)
5 Microbiome Drugs Breakdown Data by Symptom
5.1 Global Microbiome Drugs Historic Market Size by Symptom (2016-2021)
5.2 Global Microbiome Drugs Forecasted Market Size by Symptom (2022-2027)
6 North America
6.1 North America Microbiome Drugs Market Size (2016-2027)
6.2 North America Microbiome Drugs Market Size by Type
6.2.1 North America Microbiome Drugs Market Size by Type (2016-2021)
6.2.2 North America Microbiome Drugs Market Size by Type (2022-2027)
6.2.3 North America Microbiome Drugs Market Size by Type (2016-2027)
6.3 North America Microbiome Drugs Market Size by Symptom
6.3.1 North America Microbiome Drugs Market Size by Symptom (2016-2021)
6.3.2 North America Microbiome Drugs Market Size by Symptom (2022-2027)
6.3.3 North America Microbiome Drugs Market Size by Symptom (2016-2027)
6.4 North America Microbiome Drugs Market Size by Country
6.4.1 North America Microbiome Drugs Market Size by Country (2016-2021)
6.4.2 North America Microbiome Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Microbiome Drugs Market Size (2016-2027)
7.2 Europe Microbiome Drugs Market Size by Type
7.2.1 Europe Microbiome Drugs Market Size by Type (2016-2021)
7.2.2 Europe Microbiome Drugs Market Size by Type (2022-2027)
7.2.3 Europe Microbiome Drugs Market Size by Type (2016-2027)
7.3 Europe Microbiome Drugs Market Size by Symptom
7.3.1 Europe Microbiome Drugs Market Size by Symptom (2016-2021)
7.3.2 Europe Microbiome Drugs Market Size by Symptom (2022-2027)
7.3.3 Europe Microbiome Drugs Market Size by Symptom (2016-2027)
7.4 Europe Microbiome Drugs Market Size by Country
7.4.1 Europe Microbiome Drugs Market Size by Country (2016-2021)
7.4.2 Europe Microbiome Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Drugs Market Size (2016-2027)
8.2 Asia-Pacific Microbiome Drugs Market Size by Type
8.2.1 Asia-Pacific Microbiome Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microbiome Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microbiome Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Microbiome Drugs Market Size by Symptom
8.3.1 Asia-Pacific Microbiome Drugs Market Size by Symptom (2016-2021)
8.3.2 Asia-Pacific Microbiome Drugs Market Size by Symptom (2022-2027)
8.3.3 Asia-Pacific Microbiome Drugs Market Size by Symptom (2016-2027)
8.4 Asia-Pacific Microbiome Drugs Market Size by Region
8.4.1 Asia-Pacific Microbiome Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microbiome Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Microbiome Drugs Market Size (2016-2027)
9.2 Latin America Microbiome Drugs Market Size by Type
9.2.1 Latin America Microbiome Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Microbiome Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Microbiome Drugs Market Size by Type (2016-2027)
9.3 Latin America Microbiome Drugs Market Size by Symptom
9.3.1 Latin America Microbiome Drugs Market Size by Symptom (2016-2021)
9.3.2 Latin America Microbiome Drugs Market Size by Symptom (2022-2027)
9.3.3 Latin America Microbiome Drugs Market Size by Symptom (2016-2027)
9.4 Latin America Microbiome Drugs Market Size by Country
9.4.1 Latin America Microbiome Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Microbiome Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Drugs Market Size (2016-2027)
10.2 Middle East & Africa Microbiome Drugs Market Size by Type
10.2.1 Middle East & Africa Microbiome Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microbiome Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microbiome Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Microbiome Drugs Market Size by Symptom
10.3.1 Middle East & Africa Microbiome Drugs Market Size by Symptom (2016-2021)
10.3.2 Middle East & Africa Microbiome Drugs Market Size by Symptom (2022-2027)
10.3.3 Middle East & Africa Microbiome Drugs Market Size by Symptom (2016-2027)
10.4 Middle East & Africa Microbiome Drugs Market Size by Country
10.4.1 Middle East & Africa Microbiome Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microbiome Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Details
11.1.2 Seres Therapeutics Business Overview
11.1.3 Seres Therapeutics Microbiome Drugs Introduction
11.1.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2016-2021)
11.1.5 Seres Therapeutics Recent Development
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Details
11.2.2 Assembly Biosciences Business Overview
11.2.3 Assembly Biosciences Microbiome Drugs Introduction
11.2.4 Assembly Biosciences Revenue in Microbiome Drugs Business (2016-2021)
11.2.5 Assembly Biosciences Recent Development
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Details
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Microbiome Drugs Introduction
11.3.4 Synthetic Biologics Revenue in Microbiome Drugs Business (2016-2021)
11.3.5 Synthetic Biologics Recent Development
11.4 Interxon
11.4.1 Interxon Company Details
11.4.2 Interxon Business Overview
11.4.3 Interxon Microbiome Drugs Introduction
11.4.4 Interxon Revenue in Microbiome Drugs Business (2016-2021)
11.4.5 Interxon Recent Development
11.5 PureTech
11.5.1 PureTech Company Details
11.5.2 PureTech Business Overview
11.5.3 PureTech Microbiome Drugs Introduction
11.5.4 PureTech Revenue in Microbiome Drugs Business (2016-2021)
11.5.5 PureTech Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Microbiome Drugs Introduction
11.6.4 Synlogic Revenue in Microbiome Drugs Business (2016-2021)
11.6.5 Synlogic Recent Development
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Details
11.7.2 Enterome BioScience Business Overview
11.7.3 Enterome BioScience Microbiome Drugs Introduction
11.7.4 Enterome BioScience Revenue in Microbiome Drugs Business (2016-2021)
11.7.5 Enterome BioScience Recent Development
11.8 4D Pharma
11.8.1 4D Pharma Company Details
11.8.2 4D Pharma Business Overview
11.8.3 4D Pharma Microbiome Drugs Introduction
11.8.4 4D Pharma Revenue in Microbiome Drugs Business (2016-2021)
11.8.5 4D Pharma Recent Development
11.9 Second Genome
11.9.1 Second Genome Company Details
11.9.2 Second Genome Business Overview
11.9.3 Second Genome Microbiome Drugs Introduction
11.9.4 Second Genome Revenue in Microbiome Drugs Business (2016-2021)
11.9.5 Second Genome Recent Development
11.10 AOBiome
11.10.1 AOBiome Company Details
11.10.2 AOBiome Business Overview
11.10.3 AOBiome Microbiome Drugs Introduction
11.10.4 AOBiome Revenue in Microbiome Drugs Business (2016-2021)
11.10.5 AOBiome Recent Development
11.11 Rebiotix
11.11.1 Rebiotix Company Details
11.11.2 Rebiotix Business Overview
11.11.3 Rebiotix Microbiome Drugs Introduction
11.11.4 Rebiotix Revenue in Microbiome Drugs Business (2016-2021)
11.11.5 Rebiotix Recent Development
11.12 Metabiomics
11.12.1 Metabiomics Company Details
11.12.2 Metabiomics Business Overview
11.12.3 Metabiomics Microbiome Drugs Introduction
11.12.4 Metabiomics Revenue in Microbiome Drugs Business (2016-2021)
11.12.5 Metabiomics Recent Development
11.13 Ritter Pharmaceuticals
11.13.1 Ritter Pharmaceuticals Company Details
11.13.2 Ritter Pharmaceuticals Business Overview
11.13.3 Ritter Pharmaceuticals Microbiome Drugs Introduction
11.13.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2016-2021)
11.13.5 Ritter Pharmaceuticals Recent Development
11.14 Symberix
11.14.1 Symberix Company Details
11.14.2 Symberix Business Overview
11.14.3 Symberix Microbiome Drugs Introduction
11.14.4 Symberix Revenue in Microbiome Drugs Business (2016-2021)
11.14.5 Symberix Recent Development
11.15 OpenBiome
11.15.1 OpenBiome Company Details
11.15.2 OpenBiome Business Overview
11.15.3 OpenBiome Microbiome Drugs Introduction
11.15.4 OpenBiome Revenue in Microbiome Drugs Business (2016-2021)
11.15.5 OpenBiome Recent Development
11.16 Azitra
11.16.1 Azitra Company Details
11.16.2 Azitra Business Overview
11.16.3 Azitra Microbiome Drugs Introduction
11.16.4 Azitra Revenue in Microbiome Drugs Business (2016-2021)
11.16.5 Azitra Recent Development
11.17 Osel
11.17.1 Osel Company Details
11.17.2 Osel Business Overview
11.17.3 Osel Microbiome Drugs Introduction
11.17.4 Osel Revenue in Microbiome Drugs Business (2016-2021)
11.17.5 Osel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Microbiome Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Dosage Form
Table 3. Key Players of Enteric Capsules
Table 4. Global Microbiome Drugs Market Size Growth by Symptom (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Microbiome Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Microbiome Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Microbiome Drugs Market Share by Regions (2016-2021)
Table 8. Global Microbiome Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Microbiome Drugs Market Share by Regions (2022-2027)
Table 10. Microbiome Drugs Market Trends
Table 11. Microbiome Drugs Market Drivers
Table 12. Microbiome Drugs Market Challenges
Table 13. Microbiome Drugs Market Restraints
Table 14. Global Microbiome Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Microbiome Drugs Market Share by Players (2016-2021)
Table 16. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Drugs as of 2020)
Table 17. Ranking of Global Top Microbiome Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Microbiome Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Microbiome Drugs Product Solution and Service
Table 21. Date of Enter into Microbiome Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Microbiome Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Microbiome Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Microbiome Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Microbiome Drugs Market Size Share by Symptom (2016-2021) & (US$ Million)
Table 28. Global Microbiome Drugs Revenue Market Share by Symptom (2016-2021)
Table 29. Global Microbiome Drugs Forecasted Market Size by Symptom (2022-2027) (US$ Million)
Table 30. Global Microbiome Drugs Revenue Market Share by Symptom (2022-2027) & (US$ Million)
Table 31. North America Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Microbiome Drugs Market Size by Symptom (2016-2021) (US$ Million)
Table 34. North America Microbiome Drugs Market Size by Symptom (2022-2027) & (US$ Million)
Table 35. North America Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Microbiome Drugs Market Size by Symptom (2016-2021) (US$ Million)
Table 40. Europe Microbiome Drugs Market Size by Symptom (2022-2027) & (US$ Million)
Table 41. Europe Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Microbiome Drugs Market Size by Symptom (2016-2021) (US$ Million)
Table 46. Asia-Pacific Microbiome Drugs Market Size by Symptom (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Microbiome Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Microbiome Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Microbiome Drugs Market Size by Symptom (2016-2021) (US$ Million)
Table 52. Latin America Microbiome Drugs Market Size by Symptom (2022-2027) & (US$ Million)
Table 53. Latin America Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Microbiome Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Microbiome Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Microbiome Drugs Market Size by Symptom (2016-2021) (US$ Million)
Table 58. Middle East & Africa Microbiome Drugs Market Size by Symptom (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Seres Therapeutics Company Details
Table 62. Seres Therapeutics Business Overview
Table 63. Seres Therapeutics Microbiome Drugs Product
Table 64. Seres Therapeutics Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 65. Seres Therapeutics Recent Development
Table 66. Assembly Biosciences Company Details
Table 67. Assembly Biosciences Business Overview
Table 68. Assembly Biosciences Microbiome Drugs Product
Table 69. Assembly Biosciences Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 70. Assembly Biosciences Recent Development
Table 71. Synthetic Biologics Company Details
Table 72. Synthetic Biologics Business Overview
Table 73. Synthetic Biologics Microbiome Drugs Product
Table 74. Synthetic Biologics Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 75. Synthetic Biologics Recent Development
Table 76. Interxon Company Details
Table 77. Interxon Business Overview
Table 78. Interxon Microbiome Drugs Product
Table 79. Interxon Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 80. Interxon Recent Development
Table 81. PureTech Company Details
Table 82. PureTech Business Overview
Table 83. PureTech Microbiome Drugs Product
Table 84. PureTech Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 85. PureTech Recent Development
Table 86. Synlogic Company Details
Table 87. Synlogic Business Overview
Table 88. Synlogic Microbiome Drugs Product
Table 89. Synlogic Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 90. Synlogic Recent Development
Table 91. Enterome BioScience Company Details
Table 92. Enterome BioScience Business Overview
Table 93. Enterome BioScience Microbiome Drugs Product
Table 94. Enterome BioScience Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 95. Enterome BioScience Recent Development
Table 96. 4D Pharma Company Details
Table 97. 4D Pharma Business Overview
Table 98. 4D Pharma Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 99. 4D Pharma Recent Development
Table 100. Second Genome Company Details
Table 101. Second Genome Business Overview
Table 102. Second Genome Microbiome Drugs Product
Table 103. Second Genome Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 104. Second Genome Recent Development
Table 105. AOBiome Company Details
Table 106. AOBiome Business Overview
Table 107. AOBiome Microbiome Drugs Product
Table 108. AOBiome Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 109. AOBiome Recent Development
Table 110. Rebiotix Company Details
Table 111. Rebiotix Business Overview
Table 112. Rebiotix Microbiome Drugs Product
Table 113. Rebiotix Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 114. Rebiotix Recent Development
Table 115. Metabiomics Company Details
Table 116. Metabiomics Business Overview
Table 117. Metabiomics Microbiome Drugs Product
Table 118. Metabiomics Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 119. Metabiomics Recent Development
Table 120. Ritter Pharmaceuticals Company Details
Table 121. Ritter Pharmaceuticals Business Overview
Table 122. Ritter Pharmaceuticals Microbiome Drugs Product
Table 123. Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 124. Ritter Pharmaceuticals Recent Development
Table 125. Symberix Company Details
Table 126. Symberix Business Overview
Table 127. Symberix Microbiome Drugs Product
Table 128. Symberix Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 129. Symberix Recent Development
Table 130. OpenBiome Company Details
Table 131. OpenBiome Business Overview
Table 132. OpenBiome Microbiome Drugs Product
Table 133. OpenBiome Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 134. OpenBiome Recent Development
Table 135. Azitra Company Details
Table 136. Azitra Business Overview
Table 137. Azitra Microbiome Drugs Product
Table 138. Azitra Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 139. Azitra Recent Development
Table 140. Osel Company Details
Table 141. Osel Business Overview
Table 142. Osel Microbiome Drugs Product
Table 143. Osel Revenue in Microbiome Drugs Business (2016-2021) & (US$ Million)
Table 144. Osel Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Dosage Form Features
Figure 3. Enteric Capsules Features
Figure 4. Global Microbiome Drugs Market Share by Symptom: 2020 VS 2027
Figure 5. Gastrointestinal Disorders Case Studies
Figure 6. Autoimmune Disorders Case Studies
Figure 7. Diabetes Case Studies
Figure 8. Cancer Case Studies
Figure 9. Others Case Studies
Figure 10. Microbiome Drugs Report Years Considered
Figure 11. Global Microbiome Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Microbiome Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Microbiome Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Microbiome Drugs Market Share by Regions (2022-2027)
Figure 15. Global Microbiome Drugs Market Share by Players in 2020
Figure 16. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Microbiome Drugs Revenue in 2020
Figure 18. Global Microbiome Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Microbiome Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Microbiome Drugs Market Share by Type (2016-2027)
Figure 22. North America Microbiome Drugs Market Share by Symptom (2016-2027)
Figure 23. North America Microbiome Drugs Market Share by Country (2016-2027)
Figure 24. United States Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Microbiome Drugs Market Share by Type (2016-2027)
Figure 28. Europe Microbiome Drugs Market Share by Symptom (2016-2027)
Figure 29. Europe Microbiome Drugs Market Share by Country (2016-2027)
Figure 30. Germany Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Microbiome Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Microbiome Drugs Market Share by Symptom (2016-2027)
Figure 39. Asia-Pacific Microbiome Drugs Market Share by Region (2016-2027)
Figure 40. China Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Microbiome Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Microbiome Drugs Market Share by Symptom (2016-2027)
Figure 49. Latin America Microbiome Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Microbiome Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Microbiome Drugs Market Share by Symptom (2016-2027)
Figure 55. Middle East & Africa Microbiome Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Microbiome Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 60. Assembly Biosciences Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 61. Synthetic Biologics Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 62. Interxon Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 63. PureTech Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 64. Synlogic Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 65. Enterome BioScience Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 66. 4D Pharma Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 67. Second Genome Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 68. AOBiome Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 69. Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 70. Metabiomics Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 71. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 72. Symberix Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 73. OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 74. Azitra Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 75. Osel Revenue Growth Rate in Microbiome Drugs Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs